Croda International (LSE:CRDA) delivered a solid first-half performance in 2026, with group revenue rising 2.9% to £880.5 million and organic sales growth of 4.6%. Consumer Care remained the key growth driver, with sales increasing 8%, supported by strong demand across several product categories. Beauty Actives recorded growth of 19%, while Beauty Care, Home Care, and Fragrances & Flavours increased by 4%, 9%, and 8% respectively. These gains helped adjusted operating profit rise 6.7% to £155.8 million, with the adjusted operating margin improving to 17.7% despite modest currency headwinds.
While Life Sciences delivered broadly stable sales and Industrial Specialties experienced a decline, the group generated profit growth that outpaced revenue growth, supported by increasing demand for innovative and protected products. Croda also benefited from the early impact of its transformation programme, which delivered £18 million of incremental cost savings during the first half. Free cash flow increased 36.8% to £38.3 million, while leverage improved slightly to 1.4 times. Management reaffirmed its full-year 2026 guidance, maintaining expectations for organic growth of between 3% and 6% alongside further margin expansion, reflecting confidence in its long-term strategy despite ongoing macroeconomic and geopolitical challenges.
The company’s outlook remains underpinned by a strong financial position, supported by healthy cash generation and manageable leverage levels. Technical indicators also remain constructive, although valuation continues to be demanding due to the company’s relatively high price-to-earnings multiple. Management also acknowledged execution risks, including exceptional charges and varying performance across business segments, although progress on the transformation programme and reaffirmed guidance provide additional confidence.
About Croda International
Croda International is a global specialty chemicals company that develops high-performance ingredients and technologies for the consumer care, life sciences and industrial sectors. Its portfolio includes ingredients for beauty and personal care products, home care applications, pharmaceutical excipients, and crop and seed enhancement solutions. The company focuses on innovation-led, higher-value products designed to support sustainable growth and improve customer performance across global markets.
Leave a Reply